{"id":328,"date":"2026-09-03T13:39:10","date_gmt":"2026-09-03T20:39:10","guid":{"rendered":"https:\/\/www.theranostec.com\/?page_id=328"},"modified":"2026-09-03T13:39:10","modified_gmt":"2026-09-03T20:39:10","slug":"preview-khaki-v2","status":"publish","type":"page","link":"https:\/\/www.theranostec.com\/?page_id=328","title":{"rendered":"Theranostec Preview \u2014 Khaki (Isolated)"},"content":{"rendered":"<p><iframe class=\"theranostec-preview-frame\" title=\"Preview Khaki\" srcdoc=\"&lt;!doctype html&gt;&lt;html lang=&quot;en&quot;&gt;&lt;head&gt;&lt;meta charset=&quot;utf-8&quot;&gt;&lt;meta name=&quot;viewport&quot; content=&quot;width=device-width, initial-scale=1&quot;&gt;&lt;base href=&quot;https:\/\/www.theranostec.com\/&quot;&gt;&lt;style&gt;@import url(&#x27;https:\/\/fonts.googleapis.com\/css2?family=DM+Mono:wght@400;500&amp;family=Manrope:wght@400;500;600;700;800&amp;display=swap&#x27;);\n\n:root {\n  --ink: #18212a;\n  --paper: #f5f3ed;\n  --paper-2: #e9e7df;\n  --line: #b8b9b1;\n  --orange: #e4623c;\n  --blue: #5063d9;\n  --muted: #68727a;\n  --rail: 272px;\n  --max: 1450px;\n  --font-sans: Manrope, Arial, sans-serif;\n  --font-mono: &#x27;DM Mono&#x27;, monospace;\n  --body-size: 16px;\n  --grid-title-size: 24px;\n}\n\n* { box-sizing: border-box; }\nhtml { scroll-behavior: smooth; }\nbody {\n  margin: 0;\n  background: var(--paper);\n  color: var(--ink);\n  font-family: var(--font-sans);\n  font-size: var(--body-size);\n  line-height: 1.6;\n}\na { color: inherit; }\nh1, h2, h3, p { margin-top: 0; }\n\n.skip-link {\n  position: absolute;\n  left: -999px;\n  top: 10px;\n  background: #fff;\n  padding: 8px 12px;\n  z-index: 10;\n}\n.skip-link:focus { left: 10px; }\n.page-shell {\n  display: grid;\n  grid-template-columns: var(--rail) 1fr;\n  min-height: 100vh;\n}\n\n.rail {\n  position: sticky;\n  top: 0;\n  height: 100vh;\n  border-right: 1px solid var(--ink);\n  display: flex;\n  flex-direction: column;\n  padding: 28px 25px 24px;\n  background: var(--paper);\n}\n.wordmark {\n  display: block;\n  width: 100%;\n  max-width: 210px;\n  text-decoration: none;\n}\n.site-logo {\n  display: block;\n  width: 100%;\n  height: auto;\n}\n.rail-nav {\n  display: flex;\n  flex-direction: column;\n  gap: 15px;\n  margin-top: 70px;\n}\n.rail-nav a {\n  text-decoration: none;\n  display: flex;\n  gap: 18px;\n  align-items: center;\n  font-size: 14px;\n}\n.rail-nav a:hover {\n  text-decoration: underline;\n  text-underline-offset: 4px;\n}\n.rail-nav span,\n.section-label,\n.eyebrow,\n.kicker,\n.program-meta,\n.program-foot,\n.evidence-type,\n.caps,\n.rail-bottom,\n.person-index {\n  font-family: var(--font-mono);\n  text-transform: uppercase;\n  letter-spacing: .08em;\n  font-size: 11px;\n}\n.rail-nav span {\n  color: var(--muted);\n  width: 22px;\n}\n.rail-bottom {\n  margin-top: auto;\n  display: flex;\n  justify-content: space-between;\n  color: var(--muted);\n  font-size: 10px;\n}\n.menu-toggle { display: none; }\n\n.masthead,\n.section,\n.footer {\n  max-width: var(--max);\n  margin: 0 auto;\n  padding-left: clamp(28px, 6vw, 100px);\n  padding-right: clamp(28px, 6vw, 100px);\n}\n.masthead { padding-top: 40px; }\n.eyebrow {\n  border-top: 1px solid var(--ink);\n  padding-top: 12px;\n  color: var(--muted);\n}\n.masthead-grid {\n  display: grid;\n  grid-template-columns: minmax(0, 1fr) minmax(340px, .9fr);\n  gap: 7vw;\n  align-items: end;\n  padding: 75px 0 55px;\n}\n.kicker {\n  color: var(--orange);\n  margin: 0 0 22px;\n}\nh1 {\n  font-family: var(--font-sans);\n  font-size: clamp(52px, 6.6vw, 96px);\n  line-height: .98;\n  letter-spacing: -.055em;\n  margin: 0 0 32px;\n  font-weight: 700;\n}\nh1 em,\nh2 em {\n  font: inherit;\n  font-style: normal;\n  color: var(--orange);\n}\n.intro {\n  font-family: var(--font-sans);\n  font-size: 18px;\n  line-height: 1.55;\n  max-width: 610px;\n  color: #39444e;\n}\n.mast-actions {\n  display: flex;\n  align-items: center;\n  gap: 26px;\n  margin-top: 33px;\n}\n.button {\n  display: inline-flex;\n  gap: 28px;\n  align-items: center;\n  text-decoration: none;\n  padding: 13px 17px;\n  font-size: 14px;\n  font-weight: 700;\n}\n.button-dark {\n  background: var(--ink);\n  color: var(--paper);\n}\n.text-link {\n  text-decoration: none;\n  border-bottom: 1px solid var(--ink);\n  padding-bottom: 3px;\n  font-size: 14px;\n}\n.mast-figure { margin: 0; }\n.mast-figure img {\n  width: 100%;\n  height: 430px;\n  object-fit: cover;\n  filter: grayscale(25%);\n  display: block;\n}\n.mast-figure figcaption,\n.wide-figure figcaption {\n  display: flex;\n  justify-content: space-between;\n  gap: 10px;\n  margin-top: 9px;\n  color: var(--muted);\n  font: 10px var(--font-mono);\n  text-transform: uppercase;\n  letter-spacing: .05em;\n}\n.signal-row {\n  display: grid;\n  grid-template-columns: repeat(3, 1fr);\n  border-top: 1px solid var(--ink);\n  border-bottom: 1px solid var(--ink);\n  padding: 19px 0;\n  margin-bottom: 24px;\n}\n.signal-row div {\n  display: flex;\n  gap: 20px;\n  align-items: center;\n}\n.signal-row strong {\n  font-size: 13px;\n  font-weight: 600;\n}\n.signal-num {\n  font: 11px var(--font-mono);\n  color: var(--orange);\n}\n\n.section {\n  display: grid;\n  grid-template-columns: 160px 1fr;\n  gap: clamp(20px, 5vw, 90px);\n  padding-top: 115px;\n  padding-bottom: 115px;\n  border-top: 1px solid var(--line);\n}\n.section-label {\n  display: flex;\n  gap: 12px;\n  align-items: flex-start;\n  color: var(--muted);\n}\n.section-label span:first-child { color: var(--orange); }\n.section-body { min-width: 0; }\nh2 {\n  font-family: var(--font-sans);\n  font-size: clamp(36px, 3.8vw, 58px);\n  line-height: 1.08;\n  letter-spacing: -.045em;\n  margin-bottom: 28px;\n  font-weight: 700;\n  max-width: 800px;\n}\nh3 {\n  font-family: var(--font-sans);\n  font-size: var(--grid-title-size);\n  line-height: 1.2;\n  letter-spacing: -.02em;\n  margin-bottom: 9px;\n  font-weight: 700;\n}\n.overview-grid p,\n.program-intro p,\n.program-card p,\n.development-grid p,\n.development-list p,\n.evidence-item p,\n.company-grid p,\n.person small,\n.advisors p {\n  font-family: var(--font-sans);\n  font-size: var(--body-size);\n  line-height: 1.6;\n}\n\n.overview-grid,\n.development-grid,\n.company-grid,\n.evidence-grid {\n  display: grid;\n  grid-template-columns: 1fr 1fr;\n  gap: 7vw;\n}\n.overview-grid p { max-width: 560px; }\n.program-intro {\n  display: grid;\n  grid-template-columns: 1fr 1fr;\n  gap: 7vw;\n  margin-bottom: 42px;\n}\n.program-intro p { color: var(--muted); }\n.program-card {\n  padding: 25px 28px 0;\n  margin-bottom: 16px;\n  border: 1px solid var(--ink);\n}\n.program-primary {\n  background: var(--orange);\n  color: #211d1b;\n  border-color: var(--orange);\n}\n.program-secondary {\n  background: var(--blue);\n  color: #f6f4ee;\n  border-color: var(--blue);\n}\n.program-meta {\n  display: flex;\n  justify-content: space-between;\n  font-size: 10px;\n  border-bottom: 1px solid currentColor;\n  padding-bottom: 13px;\n}\n.program-card-grid {\n  display: grid;\n  grid-template-columns: .8fr 1.2fr;\n  gap: 6vw;\n  padding: 35px 0 28px;\n}\n.program-sub {\n  font-family: var(--font-mono);\n  text-transform: uppercase;\n  font-size: 11px;\n  line-height: 1.5;\n  max-width: 210px;\n}\n.program-card p { font-size: var(--body-size); }\n.boundary {\n  border-left: 2px solid currentColor;\n  padding-left: 16px;\n}\n.program-foot {\n  border-top: 1px solid currentColor;\n  padding: 14px 0;\n  display: flex;\n  justify-content: space-between;\n  font-size: 10px;\n}\n.accent-orange,\n.accent-blue { font-size: 16px; }\n.accent-orange { color: #f7e5dc; }\n.accent-blue { color: #dfe2ff; }\n\n.development-section { background: var(--paper-2); }\n.development-grid { margin-bottom: 65px; }\n.development-grid &gt; div:first-child p {\n  max-width: 480px;\n  color: var(--muted);\n}\n.development-list { border-top: 1px solid var(--ink); }\n.development-list &gt; div {\n  display: grid;\n  grid-template-columns: 70px 1fr;\n  gap: 9px;\n  border-bottom: 1px solid var(--line);\n  padding: 17px 0;\n}\n.development-list span {\n  font: 11px var(--font-mono);\n  color: var(--orange);\n}\n.development-list strong {\n  font-family: var(--font-sans);\n  font-size: var(--body-size);\n}\n.development-list p {\n  grid-column: 2;\n  color: var(--muted);\n  font-size: var(--body-size);\n  margin: 0;\n}\n.wide-figure { margin: 0; }\n.wide-figure img {\n  width: 100%;\n  display: block;\n  max-height: 520px;\n  object-fit: contain;\n  object-position: left center;\n  background: #fff;\n}\n\n.muted { color: var(--muted); }\n.evidence-stack { border-top: 1px solid var(--ink); }\n.evidence-item {\n  border-bottom: 1px solid var(--line);\n  padding: 22px 0;\n}\n.evidence-type {\n  color: var(--orange);\n  font-size: 10px;\n}\n.evidence-item h3 {\n  font-size: var(--grid-title-size);\n  max-width: 700px;\n  margin: 11px 0;\n}\n.evidence-item p {\n  color: var(--muted);\n  font-size: var(--body-size);\n  margin: 0;\n}\n\n.company-section {\n  background: var(--ink);\n  color: var(--paper);\n  border-color: var(--ink);\n}\n.company-section .section-label { color: #aab1b3; }\n.company-section .section-label span:first-child { color: var(--orange); }\n.company-grid &gt; div:first-child p {\n  color: #b5bdbe;\n  max-width: 470px;\n}\n.people { border-top: 1px solid #647078; }\n.person {\n  border-bottom: 1px solid #647078;\n  padding: 22px 0;\n  display: grid;\n  grid-template-columns: 44px 1fr;\n}\n.person-index {\n  color: var(--orange);\n  padding-top: 4px;\n}\n.person h3 {\n  font-size: var(--grid-title-size);\n  margin: 0;\n}\n.person p {\n  grid-column: 2;\n  color: #b5bdbe;\n  margin: 4px 0 11px;\n  font: 11px var(--font-mono);\n  text-transform: uppercase;\n}\n.person small {\n  grid-column: 2;\n  color: #d4d8d6;\n  font-size: var(--body-size);\n  line-height: 1.6;\n}\n.advisors {\n  display: grid;\n  grid-template-columns: 44px 1fr;\n  padding-top: 24px;\n}\n.advisors .caps {\n  color: var(--orange);\n  margin: 0 0 16px;\n}\n.advisors p {\n  color: #d4d8d6;\n  font-size: var(--body-size);\n}\n\n.contact-section {\n  background: var(--orange);\n  border-color: var(--orange);\n  padding-top: 85px;\n  padding-bottom: 85px;\n}\n.contact-body {\n  display: grid;\n  grid-template-columns: 1fr 1fr;\n  gap: 7vw;\n}\n.contact-section h2 { max-width: 520px; }\n.contact-section address {\n  font-family: var(--font-sans);\n  font-style: normal;\n  font-size: var(--body-size);\n  line-height: 1.6;\n}\n.contact-section address a {\n  text-decoration: none;\n  border-bottom: 1px solid currentColor;\n}\n\n.footer {\n  display: flex;\n  align-items: center;\n  justify-content: space-between;\n  padding-top: 18px;\n  padding-bottom: 18px;\n  color: var(--muted);\n  font: 10px var(--font-mono);\n  text-transform: uppercase;\n  letter-spacing: .06em;\n}\n.footer-logo {\n  display: block;\n  width: 150px;\n  height: auto;\n}\n.footer span:last-child { text-align: right; }\n\n@media (max-width: 900px) {\n  :root { --rail: 0px; }\n  .page-shell { display: block; }\n  .rail {\n    position: relative;\n    height: auto;\n    border-right: 0;\n    border-bottom: 1px solid var(--ink);\n    padding: 16px 22px;\n  }\n  .rail-top {\n    display: flex;\n    align-items: center;\n    justify-content: space-between;\n  }\n  .wordmark { max-width: 160px; }\n  .menu-toggle {\n    display: flex;\n    align-items: center;\n    gap: 10px;\n    border: 0;\n    background: none;\n    font: 11px var(--font-mono);\n    text-transform: uppercase;\n    letter-spacing: .08em;\n    color: var(--ink);\n    cursor: pointer;\n  }\n  .menu-toggle span {\n    font-size: 18px;\n    line-height: 1;\n  }\n  .rail-nav {\n    display: none;\n    margin: 22px 0 3px;\n  }\n  .rail-nav.open { display: flex; }\n  .rail-bottom { display: none; }\n  .masthead,\n  .section,\n  .footer {\n    padding-left: 22px;\n    padding-right: 22px;\n  }\n  .masthead-grid,\n  .overview-grid,\n  .development-grid,\n  .company-grid,\n  .evidence-grid,\n  .contact-body {\n    grid-template-columns: 1fr;\n    gap: 38px;\n  }\n  .masthead-grid { padding-top: 55px; }\n  .mast-figure img { height: 300px; }\n  .signal-row {\n    grid-template-columns: 1fr;\n    gap: 12px;\n  }\n  .section {\n    grid-template-columns: 1fr;\n    gap: 22px;\n    padding-top: 75px;\n    padding-bottom: 75px;\n  }\n  .section-label { margin-bottom: 5px; }\n  .program-intro,\n  .program-card-grid {\n    grid-template-columns: 1fr;\n    gap: 18px;\n  }\n  .program-card {\n    padding-left: 19px;\n    padding-right: 19px;\n  }\n  .wide-figure img { max-height: 330px; }\n  .footer {\n    flex-direction: column;\n    align-items: flex-start;\n    gap: 8px;\n  }\n  .footer-logo {\n    width: 140px;\n  }\n  .footer span:last-child { text-align: left; }\n}\n\n@media (prefers-reduced-motion: reduce) {\n  html { scroll-behavior: auto; }\n}\n&lt;\/style&gt;&lt;\/head&gt;&lt;body&gt;\n  &lt;a class=&quot;skip-link&quot; href=&quot;#main&quot;&gt;Skip to content&lt;\/a&gt;\n  &lt;div class=&quot;page-shell&quot;&gt;\n    &lt;aside class=&quot;rail&quot; aria-label=&quot;Site index&quot;&gt;\n      &lt;div class=&quot;rail-top&quot;&gt;\n        &lt;a class=&quot;wordmark&quot; href=&quot;#top&quot; aria-label=&quot;Theranostec home&quot;&gt;&lt;img class=&quot;site-logo&quot; src=&quot;https:\/\/www.theranostec.com\/wp-content\/uploads\/2026\/09\/theranostec-logo-1.png&quot; alt=&quot;Theranostec&quot;&gt;&lt;\/a&gt;\n        &lt;button class=&quot;menu-toggle&quot; type=&quot;button&quot; aria-expanded=&quot;false&quot; aria-controls=&quot;rail-nav&quot;&gt;Index &lt;span&gt;+&lt;\/span&gt;&lt;\/button&gt;\n      &lt;\/div&gt;\n      &lt;nav id=&quot;rail-nav&quot; class=&quot;rail-nav&quot;&gt;\n        &lt;a href=&quot;#overview&quot;&gt;&lt;span&gt;00&lt;\/span&gt; Overview&lt;\/a&gt;\n        &lt;a href=&quot;#programs&quot;&gt;&lt;span&gt;01&lt;\/span&gt; Programs&lt;\/a&gt;\n        &lt;a href=&quot;#development&quot;&gt;&lt;span&gt;02&lt;\/span&gt; Development&lt;\/a&gt;\n        &lt;a href=&quot;#evidence&quot;&gt;&lt;span&gt;03&lt;\/span&gt; Evidence&lt;\/a&gt;\n        &lt;a href=&quot;#company&quot;&gt;&lt;span&gt;04&lt;\/span&gt; Company&lt;\/a&gt;\n        &lt;a href=&quot;#contact&quot;&gt;&lt;span&gt;05&lt;\/span&gt; Contact&lt;\/a&gt;\n      &lt;\/nav&gt;\n      &lt;div class=&quot;rail-bottom&quot;&gt;&lt;span&gt;Research dossier&lt;\/span&gt;&lt;span&gt;2026&lt;\/span&gt;&lt;\/div&gt;\n    &lt;\/aside&gt;\n\n    &lt;main id=&quot;main&quot;&gt;\n      &lt;header id=&quot;top&quot; class=&quot;masthead&quot;&gt;\n        &lt;div class=&quot;eyebrow&quot;&gt;Theranostec, Inc. \/ Precision oncology&lt;\/div&gt;\n        &lt;div class=&quot;masthead-grid&quot;&gt;\n          &lt;div&gt;\n            &lt;p class=&quot;kicker&quot;&gt;A working record of the science&lt;\/p&gt;\n            &lt;h1&gt;Molecular insight,&lt;br&gt;&lt;em&gt;translational&lt;\/em&gt;&lt;br&gt;nanomedicine.&lt;\/h1&gt;\n            &lt;p class=&quot;intro&quot;&gt;Theranostec develops precision nanomedicines that significantly improve both the delivery and effectiveness of cancer therapies.&lt;\/p&gt;\n            &lt;div class=&quot;mast-actions&quot;&gt;&lt;a class=&quot;button button-dark&quot; href=&quot;#programs&quot;&gt;Read the programs &lt;span&gt;\u2198&lt;\/span&gt;&lt;\/a&gt;&lt;a class=&quot;text-link&quot; href=&quot;mailto:yli@theranostec.com&quot;&gt;Partner with us&lt;\/a&gt;&lt;\/div&gt;\n          &lt;\/div&gt;\n          &lt;figure class=&quot;mast-figure&quot;&gt;\n            &lt;img src=&quot;https:\/\/www.theranostec.com\/wp-content\/uploads\/2026\/09\/lab-life.jpg&quot; alt=&quot;Researchers and a patient in a bright growing facility&quot;&gt;\n            &lt;figcaption&gt;&lt;span&gt;Fig. 00&lt;\/span&gt; Precision, effective, and safe&lt;\/figcaption&gt;\n          &lt;\/figure&gt;\n        &lt;\/div&gt;\n        &lt;div class=&quot;signal-row&quot; aria-label=&quot;Company at a glance&quot;&gt;\n          &lt;div&gt;&lt;span class=&quot;signal-num&quot;&gt;01&lt;\/span&gt;&lt;strong&gt;Oncology focused&lt;\/strong&gt;&lt;\/div&gt;\n          &lt;div&gt;&lt;span class=&quot;signal-num&quot;&gt;02&lt;\/span&gt;&lt;strong&gt;Translational nanomedicine&lt;\/strong&gt;&lt;\/div&gt;\n          &lt;div&gt;&lt;span class=&quot;signal-num&quot;&gt;03&lt;\/span&gt;&lt;strong&gt;Experiment-centered development&lt;\/strong&gt;&lt;\/div&gt;\n        &lt;\/div&gt;\n      &lt;\/header&gt;\n\n      &lt;section id=&quot;overview&quot; class=&quot;section overview-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;00&lt;\/span&gt;&lt;span&gt;Overview&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;section-body overview-grid&quot;&gt;\n          &lt;div&gt;&lt;h2&gt;A company built around the hard part: making therapies work in context.&lt;\/h2&gt;&lt;\/div&gt;\n          &lt;div&gt;&lt;p&gt;Currently, we are at pre-clinical stage with promising anti-cancer effect in vivo animal models. Our near-term plan is to file the IND application to the FDA and initiate clinical trials. Our long-term goal is to seek FDA approval.&lt;\/p&gt;&lt;p&gt;We have received several non-dilutive federal funds, including multiple SBIR Phase I and Phase II grants for optimization and IND-enabling studies that will move our two drug candidates into Phase 1 clinical trials.&lt;\/p&gt;&lt;\/div&gt;\n        &lt;\/div&gt;\n      &lt;\/section&gt;\n\n      &lt;section id=&quot;programs&quot; class=&quot;section programs-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;01&lt;\/span&gt;&lt;span&gt;Programs&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;section-body&quot;&gt;\n          &lt;div class=&quot;program-intro&quot;&gt;&lt;div&gt;&lt;h2&gt;Two routes into precision oncology.&lt;\/h2&gt;&lt;\/div&gt;&lt;p&gt;The program view separates the translational nanomedicine work from the research-stage structure-aware AI direction. Maturity labels follow the website update plan; specific indications and milestones remain subject to final verification.&lt;\/p&gt;&lt;\/div&gt;\n          &lt;article class=&quot;program-card program-primary&quot;&gt;\n            &lt;div class=&quot;program-meta&quot;&gt;&lt;span&gt;01 \/ Translational&lt;\/span&gt;&lt;span&gt;Preclinical&lt;\/span&gt;&lt;\/div&gt;\n            &lt;div class=&quot;program-card-grid&quot;&gt;&lt;div&gt;&lt;h3&gt;ORION-BAQ&lt;\/h3&gt;&lt;p class=&quot;program-sub&quot;&gt;Precision nanomedicine and oncology development&lt;\/p&gt;&lt;\/div&gt;&lt;div&gt;&lt;p&gt;Theranostec developed a nano-autophagy inhibitor by integrating the power of nanotechnology and medicinal chemistry. Our drug can effectively eradicate cancer cells, particularly cancer stem cells while sparing normal cells.&lt;\/p&gt;&lt;p&gt;Our nano drug is effective as a single agent or in combination therapy. Our research shows tremendous success metrics in maintenance therapy to inhibit tumor recurrence.&lt;\/p&gt;&lt;\/div&gt;&lt;\/div&gt;\n            &lt;div class=&quot;program-foot&quot;&gt;&lt;span&gt;Self-assembly \/ tumor delivery \/ therapy development&lt;\/span&gt;&lt;span class=&quot;accent-orange&quot;&gt;A&lt;\/span&gt;&lt;\/div&gt;\n          &lt;\/article&gt;\n          &lt;article class=&quot;program-card program-secondary&quot;&gt;\n            &lt;div class=&quot;program-meta&quot;&gt;&lt;span&gt;02 \/ Research platform&lt;\/span&gt;&lt;span&gt;Research-stage&lt;\/span&gt;&lt;\/div&gt;\n            &lt;div class=&quot;program-card-grid&quot;&gt;&lt;div&gt;&lt;h3&gt;SPEI-Pharm&lt;\/h3&gt;&lt;p class=&quot;program-sub&quot;&gt;Structure-aware AI research&lt;\/p&gt;&lt;\/div&gt;&lt;div&gt;&lt;p&gt;Research-stage methods that combine protein structure, candidate-molecule information, and experimental context to prioritize experimentally testable molecular and structural hypotheses.&lt;\/p&gt;&lt;p class=&quot;boundary&quot;&gt;Research-stage framing: this work proposes and ranks hypotheses; it does not independently prove binding, affinity, efficacy, or mechanism of action.&lt;\/p&gt;&lt;\/div&gt;&lt;\/div&gt;\n            &lt;div class=&quot;program-foot&quot;&gt;&lt;span&gt;Structure hypotheses \/ uncertainty \/ experimental hand-off&lt;\/span&gt;&lt;span class=&quot;accent-blue&quot;&gt;B&lt;\/span&gt;&lt;\/div&gt;\n          &lt;\/article&gt;\n        &lt;\/div&gt;\n      &lt;\/section&gt;\n\n      &lt;section id=&quot;development&quot; class=&quot;section development-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;02&lt;\/span&gt;&lt;span&gt;Development&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;section-body development-grid&quot;&gt;\n          &lt;div&gt;&lt;h2&gt;Evidence informs the next experiment.&lt;\/h2&gt;&lt;p&gt;We attack the problem at its root, overcoming resistance and preventing cancer recurrence. Experimental evidence informs subsequent design and prioritization decisions.&lt;\/p&gt;&lt;\/div&gt;\n          &lt;div class=&quot;development-list&quot;&gt;\n            &lt;div&gt;&lt;span&gt;02.1&lt;\/span&gt;&lt;strong&gt;Medicinal chemistry&lt;\/strong&gt;&lt;p&gt;Candidate optimization and nano-drug development.&lt;\/p&gt;&lt;\/div&gt;\n            &lt;div&gt;&lt;span&gt;02.2&lt;\/span&gt;&lt;strong&gt;Structural and functional experiments&lt;\/strong&gt;&lt;p&gt;Binding, structure, and function are considered as experimental questions.&lt;\/p&gt;&lt;\/div&gt;\n            &lt;div&gt;&lt;span&gt;02.3&lt;\/span&gt;&lt;strong&gt;Cancer models&lt;\/strong&gt;&lt;p&gt;In vivo evidence and translational validation.&lt;\/p&gt;&lt;\/div&gt;\n            &lt;div&gt;&lt;span&gt;02.4&lt;\/span&gt;&lt;strong&gt;Formulation and CMC&lt;\/strong&gt;&lt;p&gt;Optimization and IND-enabling studies.&lt;\/p&gt;&lt;\/div&gt;\n          &lt;\/div&gt;\n        &lt;\/div&gt;\n        &lt;figure class=&quot;wide-figure&quot;&gt;&lt;img src=&quot;https:\/\/www.theranostec.com\/wp-content\/uploads\/2026\/09\/nanotransformer.png&quot; alt=&quot;Nanoparticle assembly and tumor delivery schematic&quot;&gt;&lt;figcaption&gt;&lt;span&gt;Fig. 02&lt;\/span&gt; Nanomedicine assembly, delivery, imaging, and intracellular release&lt;\/figcaption&gt;&lt;\/figure&gt;\n      &lt;\/section&gt;\n\n      &lt;section id=&quot;evidence&quot; class=&quot;section evidence-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;03&lt;\/span&gt;&lt;span&gt;Evidence&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;section-body evidence-grid&quot;&gt;\n          &lt;div&gt;&lt;h2&gt;Selected record.&lt;\/h2&gt;&lt;p class=&quot;muted&quot;&gt;Publications, patents, and federal support carried forward from the existing site.&lt;\/p&gt;&lt;\/div&gt;\n          &lt;div class=&quot;evidence-stack&quot;&gt;\n            &lt;article class=&quot;evidence-item&quot;&gt;&lt;span class=&quot;evidence-type&quot;&gt;Publication \/ 2020&lt;\/span&gt;&lt;h3&gt;Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy.&lt;\/h3&gt;&lt;p&gt;Ma et al \u00b7 Nature Communications, 11, Article number: 4615&lt;\/p&gt;&lt;\/article&gt;\n            &lt;article class=&quot;evidence-item&quot;&gt;&lt;span class=&quot;evidence-type&quot;&gt;Publication \/ 2022&lt;\/span&gt;&lt;h3&gt;A pH\u2010Driven Small\u2010Molecule Nanotransformer Hijacks Lysosomes and Overcomes Autophagy\u2010Induced Resistance in Cancer.&lt;\/h3&gt;&lt;p&gt;Ma et al \u00b7 Angewandte Chemie International Edition, Volume 61, Issue 35, e202204567&lt;\/p&gt;&lt;\/article&gt;\n            &lt;article class=&quot;evidence-item&quot;&gt;&lt;span class=&quot;evidence-type&quot;&gt;Federal support&lt;\/span&gt;&lt;h3&gt;Multiple SBIR Phase I and Phase II grants.&lt;\/h3&gt;&lt;p&gt;Funding statement carried forward from the existing site: $4.7 Million.&lt;\/p&gt;&lt;\/article&gt;\n            &lt;article class=&quot;evidence-item&quot;&gt;&lt;span class=&quot;evidence-type&quot;&gt;Intellectual property&lt;\/span&gt;&lt;h3&gt;Strong patent protection.&lt;\/h3&gt;&lt;p&gt;The chemical composition of our new drugs, the nanoparticle technology and applications are under strong patent protection.&lt;\/p&gt;&lt;\/article&gt;\n          &lt;\/div&gt;\n        &lt;\/div&gt;\n      &lt;\/section&gt;\n\n      &lt;section id=&quot;company&quot; class=&quot;section company-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;04&lt;\/span&gt;&lt;span&gt;Company&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;section-body company-grid&quot;&gt;\n          &lt;div&gt;&lt;h2&gt;The people behind the record.&lt;\/h2&gt;&lt;p&gt;Theranostec is led by scientists and translational operators with experience in cancer drug development, nanomedicine, toxicology, clinical pathology, and cGMP production.&lt;\/p&gt;&lt;\/div&gt;\n          &lt;div class=&quot;people&quot;&gt;\n            &lt;article class=&quot;person&quot;&gt;&lt;span class=&quot;person-index&quot;&gt;01&lt;\/span&gt;&lt;h3&gt;Yuanpei Li, PhD&lt;\/h3&gt;&lt;p&gt;Founder &amp;amp; CEO&lt;\/p&gt;&lt;small&gt;Professor at the University of California, Davis&lt;br&gt;Elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE)&lt;br&gt;Expert in cancer drug development, nanomedicine, and cGMP production.&lt;\/small&gt;&lt;\/article&gt;\n            &lt;article class=&quot;person&quot;&gt;&lt;span class=&quot;person-index&quot;&gt;02&lt;\/span&gt;&lt;h3&gt;Tzu-yin Cindy Lin, DVM, PhD, DACVP&lt;\/h3&gt;&lt;p&gt;Co-Founder &amp;amp; COO&lt;\/p&gt;&lt;small&gt;Research associated Professor at the University of California, Davis&lt;br&gt;Expert in translational cancer research, Toxicology\/Clinical pathology, and nanomedicine.&lt;\/small&gt;&lt;\/article&gt;\n            &lt;div class=&quot;advisors&quot;&gt;&lt;span class=&quot;person-index&quot;&gt;03&lt;\/span&gt;&lt;div&gt;&lt;p class=&quot;caps&quot;&gt;Advisors&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Edward J. Kim MD, PhD&lt;\/strong&gt;&lt;br&gt;Associate Professor of Medicine; Medical Director \u2013 Office of Clinical Research, UC Davis Comprehensive Cancer Center.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Andrew C. Birkeland, MD&lt;\/strong&gt;&lt;br&gt;Surgeon-scientist, Department of Otolaryngology-Head and Neck Surgery, University of California, Davis.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Dr. Rick Harkins&lt;\/strong&gt;&lt;br&gt;NIH CAP advisor; prior Principal Scientist at Bayer Healthcare.&lt;\/p&gt;&lt;p&gt;&lt;strong&gt;Lloyd Kunimoto&lt;\/strong&gt;&lt;br&gt;CEO of Amfora, Inc.&lt;\/p&gt;&lt;\/div&gt;&lt;\/div&gt;\n          &lt;\/div&gt;\n        &lt;\/div&gt;\n      &lt;\/section&gt;\n\n      &lt;section id=&quot;contact&quot; class=&quot;section contact-section&quot;&gt;\n        &lt;div class=&quot;section-label&quot;&gt;&lt;span&gt;05&lt;\/span&gt;&lt;span&gt;Contact&lt;\/span&gt;&lt;\/div&gt;\n        &lt;div class=&quot;contact-body&quot;&gt;&lt;div&gt;&lt;p class=&quot;kicker&quot;&gt;Open to the right conversation&lt;\/p&gt;&lt;h2&gt;Partner with Theranostec.&lt;\/h2&gt;&lt;\/div&gt;&lt;address&gt;&lt;strong&gt;Theranostec, Inc.&lt;\/strong&gt;&lt;br&gt;2700 Stockton Boulevard&lt;br&gt;Sacramento CA, 95817&lt;br&gt;&lt;br&gt;&lt;a href=&quot;mailto:yli@theranostec.com&quot;&gt;yli@theranostec.com&lt;\/a&gt;&lt;br&gt;&lt;a href=&quot;https:\/\/www.theranostec.com&quot;&gt;www.theranostec.com&lt;\/a&gt;&lt;\/address&gt;&lt;\/div&gt;\n      &lt;\/section&gt;\n\n      &lt;footer class=&quot;footer&quot;&gt;&lt;img class=&quot;footer-logo&quot; src=&quot;https:\/\/www.theranostec.com\/wp-content\/uploads\/2026\/09\/theranostec-logo-1.png&quot; alt=&quot;Theranostec&quot;&gt;&lt;span&gt;\u00a9 &lt;span id=&quot;year&quot;&gt;2026&lt;\/span&gt; Theranostec, Inc.&lt;\/span&gt;&lt;\/footer&gt;\n    &lt;\/main&gt;\n  &lt;\/div&gt;\n  \n&lt;script&gt;const toggle = document.querySelector(&#x27;.menu-toggle&#x27;);\nconst nav = document.querySelector(&#x27;.rail-nav&#x27;);\nif (toggle &amp;&amp; nav) {\n  toggle.addEventListener(&#x27;click&#x27;, () =&gt; {\n    const open = nav.classList.toggle(&#x27;open&#x27;);\n    toggle.setAttribute(&#x27;aria-expanded&#x27;, String(open));\n    toggle.querySelector(&#x27;span&#x27;).textContent = open ? &#x27;\u2212&#x27; : &#x27;+&#x27;;\n  });\n  nav.querySelectorAll(&#x27;a&#x27;).forEach((link) =&gt; link.addEventListener(&#x27;click&#x27;, () =&gt; {\n    nav.classList.remove(&#x27;open&#x27;);\n    toggle.setAttribute(&#x27;aria-expanded&#x27;, &#x27;false&#x27;);\n    toggle.querySelector(&#x27;span&#x27;).textContent = &#x27;+&#x27;;\n  }));\n}\ndocument.querySelector(&#x27;#year&#x27;).textContent = new Date().getFullYear();\n&lt;\/script&gt;&lt;\/body&gt;&lt;\/html&gt;\" style=\"position:fixed;inset:0;width:100vw;height:100vh;border:0;z-index:99999;background:#fff\" loading=\"eager\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"zakra_page_container_layout":"customizer","zakra_page_sidebar_layout":"customizer","zakra_remove_content_margin":false,"zakra_sidebar":"customizer","zakra_transparent_header":"customizer","zakra_logo":0,"zakra_main_header_style":"default","zakra_menu_item_color":"","zakra_menu_item_hover_color":"","zakra_menu_item_active_color":"","zakra_menu_active_style":"","zakra_page_header":true,"footnotes":""},"class_list":["post-328","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages\/328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=328"}],"version-history":[{"count":0,"href":"https:\/\/www.theranostec.com\/index.php?rest_route=\/wp\/v2\/pages\/328\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.theranostec.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}